Warfarin and Non-Steroidal Anti-Inflammatory Drugs (NSAID) Customized Alert
Not Applicable
Completed
- Conditions
- Warfarin and NSAID
- Registration Number
- NCT00880932
- Lead Sponsor
- University of Pennsylvania
- Brief Summary
The hypothesis is that a newly formatted electronic alert that requires the prescriber to pause and enter a specific "reason for override" on this alert, will cause prescribers in the intervention group to be significantly less likely to prescribe the combination of warfarin and NSAID than prescribers in the control group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1865
Inclusion Criteria
- All resident physicians (RP) and nurse practitioners (NP) involved in inpatient care at two hospitals of the University of Pennsylvania
Exclusion Criteria
- None
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Decreased rate of prescription of the combination of warfarin and NSAID 17 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center
🇺🇸Phila, Pennsylvania, United States
Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center🇺🇸Phila, Pennsylvania, United States